Congenital malformations in patients with rhabdomyosarcoma (RMS) eligible for IRS I and I1 were reviewed in the reports of 97 complete and 17 incomplete autopsies. Using the Collaborative Perinatal Project (CPP) for the baseline incidence, an increased number of central nervous system (cNS) and genitourinary (GU) anomalies were found. Four major and 5 minor CNS anomalies were found in 99 children including diffuse microgyria with hydrocephalus, myelomeningocele with hydrocephalus and Arnold-Chiari malformation, cerebral cortical atrophy, and an enormous corpus callosum. The CPP incidence of CNS malformations was 5.29/1000. Four major and 6 minor GU anomalies were present in 110 cases including medullary/cortical hypoplasia with decreased nephrons and a double ureter, single horseshoe kidney, a multicystic kidney with cortical hypoplasia, and a simple renal cyst. The CPP incidence of GU malformations was 7.29/1000. Two major cardiovascular (CV) anomalies occurred in 109 autopsies, including a tetracuspid pulmonic valve and two accessory coronary ostia, with a CPP incidence of 8.03/1000. One case was consistent with a diagnosis of Rubenstein-Taybi syndrome; another had presumptiveneure fibromatosis. Two infants had congenital M S . The association of congenital anomalies with RMS suggests that factors during development may be both teratogenic and oncogenic.
INTERGROUP RHABDOMYOSARCOMA STUDY (IRS)
Congenital malformations in patients with rhabdomyosarcoma (RMS) eligible for IRS I and I1 were reviewed in the reports of 97 complete and 17 incomplete autopsies. Using the Collaborative Perinatal Project (CPP) for the baseline incidence, an increased number of central nervous system (cNS) and genitourinary (GU) anomalies were found. Four major and 5 minor CNS anomalies were found in 99 children including diffuse microgyria with hydrocephalus, myelomeningocele with hydrocephalus and Arnold-Chiari malformation, cerebral cortical atrophy, and an enormous corpus callosum. The CPP incidence of CNS malformations was 5.29/1000. Four major and 6 minor GU anomalies were present in 110 cases including medullary/cortical hypoplasia with decreased nephrons and a double ureter, single horseshoe kidney, a multicystic kidney with cortical hypoplasia, and a simple renal cyst. The CPP incidence of GU malformations was 7.29/1000. Two major cardiovascular (CV) anomalies occurred in 109 autopsies, including a tetracuspid pulmonic valve and two accessory coronary ostia, with a CPP incidence of 8.03/1000. One case was consistent with a diagnosis of Rubenstein-Taybi syndrome; another had presumptiveneure fibromatosis. Two infants had congenital M S . The association of congenital anomalies with RMS suggests that factors during development may be both teratogenic and oncogenic. In a newborn (46,XX) with ambiguous genitalia and bilaterally descended gonads the presumptive diagnosis of true hermaphroditism (TH) was made using endocrinological methods and a newly developed ELISA system with monoclonal H-Y antibody. Evidence for cryptic testicular tissue was obtained by measuring male levels of testosterone in plasma (117 ng/dl). 170H progesterone levels were normal thus ruling out congenital adrenal hyperplaisa.ELISA for H-Y antigen involves the reaction of monoclonal H-Y IgGantibody (AB) and cell borne or soluble antigen (AG). After that a 2nd AB (conjugated to peroxidase enzyme) is added. The amount of color (optical density) measured in a densitometer is a function of the interaction of AB and AG and consequential reaction ofperioxidase with substrate. The patient tested positive for H-Y antigen but levels were less than those found in normal males.
H-Y positive phenotypes in XX TH and XX male sex reversal obtained with this technique are consistent with the notion that the two conditions are variants of the same X-linked disorder and that the morphologic difference between the two may be relatedto the degree of inactivation of the X chromosome bearing themutant gene. TH was confirmed at surgery when ovotestes were found. Conclusion: H-Y testing using ELISA technology can be performed rapidly with small amounts of blood (5 ml). Thus this assay is particularly useful in the evaluation of newborn infants with mbiguous genitalia where quick diagnosis is essential. in deafness. The auditory brajnstem response (ABR) has-used as a hearing screening tool for newborns. We studied the potential usefulness of the ABR for detecting neonatal bilirubin toxicity using a rhesus monkey infant model.
Five rhesus monkey infants aged 1,6,20, 35, and 40 days received up to 300 mglkg of intravenous bilirubin over four hours with ABR monitoring. The one day old infant was a non-asphyxiated premature with hyaline membrane disease. If no bilirubin induced ABR change occurred, sulfisoxazole (200 mglkg) , a bilirubin displacer with no effect on the ABR, was given. Progressive ABR flattening was observed in the premature (bilirubin only) and in the 6 day old (bilirubin and sulfisoxzole). The total bilirubin concentrations at the time of ABR flattening were 33 and 60 mg% for the premature and 6 day old, respectively. The ABR in the 6 day old partially recovered in 24 hours. However, the Wave I-V latency had increased from 3.31 msec initially to 3.75 msec and the I/V amplitude ratio decreased from 2.0 to 0.7. No yellow staining was found in the brains of these two animals. No bilirubin induced ABR changes occurred in the 3 older animals.
The auditory evoked response may be a sensitive, early indicator of reversible bilirubin toxicity, and the infant rhesus monkey may be a useful paradigm for studying bilirubin toxicity. After reviewing cases brought by the conference participants and literature reports, a comprehensive checklist was compiled which represented the spectrum of features which should be considered in assessing an individual with Noonan phenotype. Subsequently, using this checklist, we have re-evaluated our own 39 patients and were able to identify two distinct groups: 23 sporadic cases and 16 familial cases (in 4 families). The four families were re-examined in detail in an attempt to delineate the intrafamilial variability and the natural history of familial cases, and to determine whether any specific phenotypic traits were pathognomonic or diagnostlc.In these four families we could identifv a characteristic facies which chaneed with aee. and a Angeles, Lallrornla. Previous work enables us to derive an equation for estimating creatinine clearance based on body length and serum creatinine in children and infants beyond the first month of life.
The purpose of the present study was to derive a simple equation for measuring creatinine clearance in appropriate for gestational age, preterm infants during the first month of life. To date, approximately one-half of the study has been completed. In 33 infants, 28-36 weeks' gestation, creatinine clearance was calculated from measurements of serum and urine (24 hour collection) creatinine. Post-natal age ranged from 4-30 days.
Gestational age, post-natal age, sex, Apgar Scores, weight, length, head circumference, serum creatinine, and aminoglycoside therapy, were subjected to multiple regression analysis. The " , range of heart lesions, stature and 1.Q.In comparing the features ratio of body weight to serum creatinine had the best correlation found in our four families to our sporadic cases, heterogeneity with creatinine clearance (r =0.63; p<0.01). The regression was obvious. At least subgroups of the Noonan phenotype could be equation is r=7.92033 + 0.00665 weightiserum creatinine (standard defined. Certain features were more commonly associated with the error of the estimate = 6.39). The predicted creatinine clearsooradlc cases than with the familial. In addition. within our auce differed from-the observed creatinine clearance by [0.09-four families there was an increased number of affected indivi-15.11 ml/min/l.73mL]. The addition of more patients will likely duals when compared to unaffected (2:1), and an increased number improve the ability to determine a stable coefficient for preof affected males compared'to affected females (2:l). These abdicting creatinine clearance. Validation of the regression normal ratios are similar to the segregation ratios found in preequation on a prospective sample will then be performed. viously reported families.
